Astria Therapeutics Inc (ATXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 0 | 0 | 500 | 0 | 0 |
| Gross Profit | N/A | N/A | 500 | N/A | N/A |
| Operating Expenses | 27,088 | 26,371 | 27,594 | 35,558 | 31,659 |
| Operating Income | -27,088 | -26,371 | -27,094 | -35,558 | -31,659 |
| Interest Expense | 0 | 100 | 462 | 837 | 978 |
| Other Income | 795 | 601 | 192 | 335 | 7 |
| Pre-tax Income | -26,293 | -25,870 | -27,364 | -36,060 | -32,630 |
| Net Income Continuous | -26,293 | -25,870 | -27,364 | -36,060 | -32,630 |
| Net Income | $-26,293 | $-25,870 | $-27,364 | $-36,060 | $-32,630 |
| EPS Basic Total Ops | -14.10 | -30.71 | -75.70 | -133.17 | -243.55 |
| EPS Basic Continuous Ops | -14.08 | -30.70 | -75.71 | -133.28 | -243.40 |
| EPS Diluted Total Ops | -14.10 | -30.71 | -75.70 | -133.17 | -243.55 |
| EPS Diluted Continuous Ops | -14.08 | -30.70 | -75.71 | -133.28 | -243.40 |
| EPS Diluted Before Non-Recurring Items | -14.10 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-27,088 | $-26,252 | $-26,790 | $-35,163 | $-31,457 |